254 related articles for article (PubMed ID: 28241864)
1. CCL2 and CCL5 driven attraction of CD172a
Zhao J; Poelaert KCK; Van Cleemput J; Nauwynck HJ
Vet Res; 2017 Feb; 48(1):14. PubMed ID: 28241864
[TBL] [Abstract][Full Text] [Related]
2. Impact of equine herpesvirus type 1 (EHV-1) infection on the migration of monocytic cells through equine nasal mucosa.
Baghi HB; Nauwynck HJ
Comp Immunol Microbiol Infect Dis; 2014 Dec; 37(5-6):321-9. PubMed ID: 25456193
[TBL] [Abstract][Full Text] [Related]
3. Equine Herpesvirus Type 1 Enhances Viral Replication in CD172a+ Monocytic Cells upon Adhesion to Endothelial Cells.
Laval K; Favoreel HW; Poelaert KC; Van Cleemput J; Nauwynck HJ
J Virol; 2015 Nov; 89(21):10912-23. PubMed ID: 26292328
[TBL] [Abstract][Full Text] [Related]
4. Equine herpesvirus type-1 modulates CCL2, CCL3, CCL5, CXCL9, and CXCL10 chemokine expression.
Wimer CL; Damiani A; Osterrieder N; Wagner B
Vet Immunol Immunopathol; 2011 Apr; 140(3-4):266-74. PubMed ID: 21349590
[TBL] [Abstract][Full Text] [Related]
5. Entry of equid herpesvirus 1 into CD172a+ monocytic cells.
Laval K; Favoreel HW; Van Cleemput J; Poelaert KCK; Brown IK; Verhasselt B; Nauwynck HJ
J Gen Virol; 2016 Mar; 97(3):733-746. PubMed ID: 26684016
[TBL] [Abstract][Full Text] [Related]
6. Equine herpesvirus type 1 replication is delayed in CD172a+ monocytic cells and controlled by histone deacetylases.
Laval K; Favoreel HW; Nauwynck HJ
J Gen Virol; 2015 Jan; 96(Pt 1):118-130. PubMed ID: 25239765
[TBL] [Abstract][Full Text] [Related]
7. Dual infections of equine herpesvirus 1 and equine arteritis virus in equine respiratory mucosa explants.
Zhao J; Negussie H; Laval K; Poelaert KC; Nauwynck HJ
Virus Res; 2016 Jul; 220():104-11. PubMed ID: 27117322
[TBL] [Abstract][Full Text] [Related]
8. Equine alphaherpesviruses (EHV-1 and EHV-4) differ in their efficiency to infect mononuclear cells during early steps of infection in nasal mucosal explants.
Vandekerckhove AP; Glorieux S; Gryspeerdt AC; Steukers L; Van Doorsselaere J; Osterrieder N; Van de Walle GR; Nauwynck HJ
Vet Microbiol; 2011 Aug; 152(1-2):21-8. PubMed ID: 21536394
[TBL] [Abstract][Full Text] [Related]
9. Detection of equine herpesvirus-specific effector and memory cytotoxic immunity in the equine upper respiratory tract.
Breathnach CC; Yeargan MR; Timoney JF; Allen GP
Vet Immunol Immunopathol; 2006 May; 111(1-2):117-25. PubMed ID: 16472871
[TBL] [Abstract][Full Text] [Related]
10. Replication of neurovirulent equine herpesvirus type 1 (EHV-1) in CD172a
Laval K; Van Cleemput J; Poelaert KC; Brown IK; Nauwynck HJ
Comp Immunol Microbiol Infect Dis; 2017 Feb; 50():58-62. PubMed ID: 28131380
[TBL] [Abstract][Full Text] [Related]
11. Effect of equine herpesvirus type 1 (EHV-1) infection of nasal mucosa epithelial cells on integrin alpha 6 and on different components of the basement membrane.
Bannazadeh Baghi H; Nauwynck HJ
Arch Virol; 2016 Jan; 161(1):103-10. PubMed ID: 26497179
[TBL] [Abstract][Full Text] [Related]
12. Deletion of the ORF2 gene of the neuropathogenic equine herpesvirus type 1 strain Ab4 reduces virulence while maintaining strong immunogenicity.
Schnabel CL; Wimer CL; Perkins G; Babasyan S; Freer H; Watts C; Rollins A; Osterrieder N; Wagner B
BMC Vet Res; 2018 Aug; 14(1):245. PubMed ID: 30134896
[TBL] [Abstract][Full Text] [Related]
13. An Equine Herpesvirus Type 1 (EHV-1) Ab4 Open Reading Frame 2 Deletion Mutant Provides Immunity and Protection from EHV-1 Infection and Disease.
Schnabel CL; Babasyan S; Rollins A; Freer H; Wimer CL; Perkins GA; Raza F; Osterrieder N; Wagner B
J Virol; 2019 Nov; 93(22):. PubMed ID: 31462575
[TBL] [Abstract][Full Text] [Related]
14. Development and application of a quantitative PCR assay to study equine herpesvirus 5 invasion and replication in equine tissues in vitro and in vivo.
Zarski LM; High EA; Nelli RK; Bolin SR; Williams KJ; Hussey G
J Virol Methods; 2017 Oct; 248():44-53. PubMed ID: 28455133
[TBL] [Abstract][Full Text] [Related]
15. Replication characteristics of equine herpesvirus 1 and equine herpesvirus 3: comparative analysis using ex vivo tissue cultures.
Negussie H; Li Y; Tessema TS; Nauwynck HJ
Vet Res; 2016 Jan; 47():19. PubMed ID: 26768993
[TBL] [Abstract][Full Text] [Related]
16. Nasal shedding of equine herpesvirus-1 from horses in an outbreak of equine herpes myeloencephalopathy in Western Canada.
Burgess BA; Tokateloff N; Manning S; Lohmann K; Lunn DP; Hussey SB; Morley PS
J Vet Intern Med; 2012; 26(2):384-92. PubMed ID: 22332764
[TBL] [Abstract][Full Text] [Related]
17. Intranasal IgG4/7 antibody responses protect horses against equid herpesvirus-1 (EHV-1) infection including nasal virus shedding and cell-associated viremia.
Perkins G; Babasyan S; Stout AE; Freer H; Rollins A; Wimer CL; Wagner B
Virology; 2019 May; 531():219-232. PubMed ID: 30928700
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of a live equine herpesvirus-1 (EHV-1) strain C147 vaccine in foals with maternally-derived antibody: protection against EHV-1 infection.
Patel JR; Didlick S; Bateman H
Equine Vet J; 2004 Jul; 36(5):447-51. PubMed ID: 15253088
[TBL] [Abstract][Full Text] [Related]
19. Temporal detection of equine herpesvirus infections of a cohort of mares and their foals.
Bell SA; Balasuriya UB; Gardner IA; Barry PA; Wilson WD; Ferraro GL; MacLachlan NJ
Vet Microbiol; 2006 Sep; 116(4):249-57. PubMed ID: 16774810
[TBL] [Abstract][Full Text] [Related]
20. Equine herpesvirus type 1 induces both neurological and respiratory disease in Syrian hamsters.
Mesquita LP; Arévalo AF; Zanatto DA; Miyashiro SI; Cunha EMS; de Souza MDCC; Villalobos EMC; Mori CMC; Maiorka PC; Mori E
Vet Microbiol; 2017 May; 203():117-124. PubMed ID: 28619133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
